Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single‐Center Study
IFDs are common in newly diagnosed ALL/LBL patients in LMICs, particularly during early phases of therapy. These infections are associated with considerable mortality, often compounded by concomitant bacterial sepsis. Given these findings, consideration of antifungal prophylaxis is warranted to mitigate morbidity and mortality due to IFDs.
Authors
- A. Murthy
- Akanksha Chichra
- Gaurav Salunke (ORCID: https://orcid.org/0000-0001-6841-8196)
- Gaurav Narula (ORCID: https://orcid.org/0000-0002-8539-295X)
- Girish Chinnaswamy (ORCID: https://orcid.org/0000-0003-0565-0523)
- Chetan Dhamne (ORCID: https://orcid.org/0000-0002-3637-2880)
- Nirmalya Roy Moulik (ORCID: https://orcid.org/0000-0001-5650-3115)
- Badira Cheriyalinkal Parambil (ORCID: https://orcid.org/0000-0001-6459-2058)
- Shripad Banavali (ORCID: https://orcid.org/0000-0002-2039-6802)
- Vasundhara Patil (ORCID: https://orcid.org/0000-0002-4177-2547)
- Venkata Rama Mohan Gollamudi
- Maya Prasad (ORCID: https://orcid.org/0000-0003-0127-7987)
- Shyam Srinivasan (ORCID: https://orcid.org/0000-0003-2587-9181)
Institutions
- Homi Bhabha National Institute (IN)
- Tata Memorial Hospital (IN)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1002/pbc.31643
- Citations
- 5
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 6.98